Zobrazeno 1 - 9 of 9 pro vyhledávání: '"R. N. Fogoros"'
2
Appropriate Indications for the Implantable Defibrillator
Autor: R. N. Fogoros
Publikováno v: Cardiac Arrhythmias 1997 ISBN: 9788847022904
After more than 15 years of clinical use, the appropriate indications for the implantable cardioverter-defibrillator (ICD) remain in controversy. The reasons for this controversy have nothing whatever to do with the efficacy of the device itself, sin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1bdd43ff53d40f21512e09412a6e7288
https://doi.org/10.1007/978-88-470-2288-1_44
Zobrazit plný text záznamu
3
Cardiac arrhythmias. Syncope and stroke
Autor: R N, Fogoros
Publikováno v: Neurologic clinics. 11(2)
Cardiac arrhythmias are an important cause of neurologic symptoms. Bradyarrhythmias and tachyarrhythmias, by disrupting blood flow to the brain and causing cerebral hypoxia, can lead to loss of consciousness (and ultimately to cerebral necrosis or de
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::29e9f875f8018b77e127d86eb9013a6a
https://pubmed.ncbi.nlm.nih.gov/8316191
Zobrazit plný text záznamu
4
Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group
Autor: S, Saksena, M, Poczobutt-Johanos, L W, Castle, R N, Fogoros, B L, Alpert, J, Kron, A, Pacifico, J, Griffin, J N, Ruskin, R F, Kehoe
Publikováno v: Journal of the American College of Cardiology. 19(3)
A second-generation implantable pacemaker-cardioverter-defibrillator was evaluated in 200 patients with sustained ventricular tachycardia, ventricular fibrillation or prior cardiac arrest. The device permits demand ventricular pacing for bradyarrhyth
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1075aa1a3b932f8cb36bbf8342cf359f
https://pubmed.ncbi.nlm.nih.gov/1537999
Zobrazit plný text záznamu
5
Disposition of moracizine (ethmozine) in healthy subjects after oral administration of radiolabelled drug
Autor: R. N. Fogoros, Charles C. Whitney, Denise L. Howrie, W. L. Schary, H. J. Pieniaszek, Randy P. Juhl, Lewis W. Dittert
Publikováno v: European Journal of Clinical Pharmacology. 32:607-610
Moracizine (ethmozine) is a phenothiazine derivative with demonstrated antiarrhythmic activity. To characterize the pharmacokinetics and material balance relationships in humans, we have given 14C-moracizine X HCl as a single oral dose of 500 mg (50
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff377e9085f8b29370d43d7d6f38aa1d
https://doi.org/10.1007/bf02455996
Zobrazit plný text záznamu
6
Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias
Autor: Kelley P. Anderson, Roger A. Winkle, Charles D. Swerdlow, R N Fogoros, Jay W. Mason
Publikováno v: Circulation. 68(1)
Ninety-six patients with recurrent, drug-refractory tachyarrhythmias were treated with amiodarone for 8.0 +/- 7.5 months (range 1 day to 27 months): 77 for recurrent ventricular tachycardia or ventricular fibrillation (VT/VF), two for complex ventric
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87ccb8f94d45709db9e977e6628c7193
https://pubmed.ncbi.nlm.nih.gov/6851057
Zobrazit plný text záznamu
8
The automatic implantable defibrillator
Autor: R N, Fogoros
Publikováno v: CVP. 12(1)
The automatic implantable defibrillator is undergoing clinical trials in the United States. The device is a self-contained unit designed to detect malignant ventricular arrhythmias as they occur and to terminate them with a defibrillating current. Ea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cce389691e255e412c0e5f669253b7d1
https://pubmed.ncbi.nlm.nih.gov/10299399
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje